Skip Ribbon Commands
Skip to main content
Menu

Assoc Prof Kee Yi Shern Terence

Dr Terence Kee from SGH

Assoc Prof Kee Yi Shern Terence

MBBS (Aust), MRCP (UK), FAMS, FRCP, FACP, FASN, GDipHML

Senior Consultant

Specialty: Renal Medicine

Sub-specialties: Renal Transplant

Conditions Treated by this Doctor:
Kidney Transplant.

Clinical Appointments

  • Programme & Medical Director, Renal Transplant Programme SingHealth Duke-NUS Transplant Centre
  • Senior Consultant SingHealth Duke-NUS Transplant Centre
  • Senior Consultant Renal Medicine Singapore General HospitalSingapore General Hospital
  • Clinical Director, Transplant Centre, SGH

Profile

​Assoc Prof Terence Kee is a senior consultant renal physician with interest in renal transplantation. He obtained his MBBS at the Flinders University of South Australia in 1994 and by 2000 completed the Singapore General Hospital basic and advanced physician training program in general and renal medicine. He subsequently received a Singapore Government Human Manpower Development Program award in 2004 to undergo a 1 year fellowship in advanced renal transplantation under Professor Jeremy Chapman at the Westmead Hospital in Australia. He returned to SGH in 2005 and has been an active member of the renal transplant team.

Education

  • MBBS (Australia) – 1995 
  • MRCP (Edinburgh) – 2000 
  • FAMS (Renal Medicine) – 2004 
  • FRCP (Edinburgh) – 2008 
  • GDipHML (Singapore Management University) - 2009 
  • FASN (United States of America) – 2013

Professional Appointments and Committee Memberships

In 2008, Dr Kee took over as Program Director of the renal transplant program at the Singapore General Hospital and became the Clinical Director of the Transplant Centre at the Singapore General Hospital in 2013. In 2015, He also was appointed as Deputy Director for Research and Education in SingHealth Transplant.
Dr Kee is also Chairman of the Chapter of Renal Physicians in the Academy of Medicine and sits on various advisory committees at the Ministry of Health of Singapore including the Transplant Advisory Committee and the Renal Transplant Advisory Sub-committee. He is also Director of Special Projects for Sengkang Hospital Planning Committee. 
He holds adjunct academic appointments at the Duke-NUS Graduate Medical School of Medicine and the Yong Loo-Lin School of Medicine at the National University of Singapore. Dr Kee is an associate editor of the Transplantation Reviews as well as Proceedings of Singapore Healthcare. Dr Kee is a member of several professional societies including the Singapore Society of Nephrology, Society of Transplantation (Singapore), American Society of Nephrology, American Society of Transplantation, International Society of Nephrology and Transplantation Society. Currently, he is President of the Society of Transplantation (Singapore). 
 
Finally, Dr Kee is the founder and team leader of SingHealth Freewheelers, a cycling club for SingHealth staff which aims to use cycling as a platform to promote health education and networking among staff in SingHealth.

Awards

  • ​2014 – Service with a heart award
  • 2013 – NUS Yong Loo Lin School of Medicine Dean Award for Teaching Excellence
  • 2012 – Service with a heart award
  • 2011 – SingHealth Residency Outstanding Mentor Award
  • 2009 – Excellent Service Award (Silver)

Research Interests

  • Immunology
  • Immunosuppression
  • Infection
  • Cancer
  • Cardiovascular disease
  • Metabolic
  • Pharmacology
  • Ethics
  • Psychosocial

Publications

 

Research interest in clinical transplantation 

 

  • Kee T, Vathsala A, Lu YM. Spectrum of Severe Infections in an Asian Renal Transplant Population. Transplant Proc 2004; 36: 2001-2003.
  • Kee T, Chapman JR, Nankivell BJ, O’Connell P, Fung CLS, Vitalone M, Allen R. Treatment of subclinical rejections in kidney transplants detected by protocol biopsies. Transplantation 2006 Jul; 82: 36-42.
  • Chian YL, Kee T, Chan KP, Oon LLE, Tan CK, Tan NSW, Tan BH. Pandemic (H1N1) 2009 infection in adult solid organ transplant recipients in Singapore. Transplantation  2010 Nov; 90(9): 1016-1021.
  • Suhail SM, Kee T, Thye WK, Khim TH, Shin YW, Meng CC, Foo MW, Hua LH, Siddique MM, Wong KS. Impact of patterns of proteinuria on renal allograft function and survival: a prospective cohort study. Clinical Transplantation 2011; 25: E297-303.
  • Bee YM, Tan HC, Tay TL, Kee T, Goh SY. Incidence and risk factors for development of new onset diabetes after kidney transplantation. Ann Acad Med Singapore 2011 Apr; 40(4): 160-167.
  • Lim D, Kee T, Fook-Chong S, Zhang RF, Chandran M. Prevalence and patterns of bone loss in the first year following renal transplant in south-east asian patients. Transplantation 2011 Sep 15; 92: 557-63.
  • The Ascertain Investigators. Conversion of Long-Term Kidney Transplant Recipients From Calcineurin Inhibitor Therapy to Everolimus: A Randomized Multicenter, 24-Month Study. Transplantation 2011 Aug 27; 92(4): 410-418.  
  • Salcido-Ochoa F, Yusof N, Hue S,  Hasae D, Kee T, Rotzsxhke O. Are we ready for the use of FOXP3+ regulatory T-cells (Tregs) for immunodiagnosis and immunotherapy in kidney transplantation. J. Transplantation 2012; 2012: 397952. Epub 2012 May 29.
  • Ow YLM, Lim C, Chow WL, Saskia VDE, Joshi VD, Lim J, Swah TS, Teo S, Goh P, Tan G,  Kee T. Factors influencing living kidney donation. Progress in Transplantation March 2012; 22(1): 95-101.
  • Chow WL, Joshi VD, Tin AS, van der Erf S, Lim JF, Swah TS, Teo SS, Goh PS, Tan GC, Lim C, Kee T. Limited knowledge of chronic kidney disease among primary care patients: A cross-sectional survey. BMC Nephrology 2012; Jul 2: 13-54.
  • Mas LM, Xu J, Li Y, Tan LE, Kee T. A survey of nurses pharmaceutical knowledge on immunosuppressive drug used in kidney transplantation. British Journal of Nursing Vol 12 Iss 13 12 Jul 2012 pp 795-800
  • Ong SC, Chow WL, Van der Erf S, Joshi VD, Lim J, Lim C, Tee PS, Lu YM, Kee T.   What factors really matter ? Health related quality of life for patients on kidney transplant waiting list. Ann Acad Med Singapore 2013; 42: 657-666.
  • Mok I, Kee T, Goh A. Ten year outcomes of kidney transplantation at the Singapore General Hospital. Proceedings of Singapore Healthcare 2012; 21(2): 95-101.
  • Tan CS, Loh HL, Foo MW, Choong LH, Wong KS, Kee T. Epstein-Barr Virus associated smooth muscle tumor after kidney transplantation: Treatment and outcomes in a single centre. Clinical Transplantation 2013 July 27(4): E462-468.
  • Kek PC, Tan HC, Kee T, Goh SY, Bee YM. Day 1 post-operative fasting hyperglycemia may affect survival in kidney transplantation. Ann Transplant 2013 Jun 7; 18: 265-272.
  • Tong A, Chapman JR, Kee T, Li P, Tsai DFC, Wong G, Craig JC. Perspectives of transplant professionals on the value, ethics and challenges of living kidney donor evaluation in Asia. Transplantation 2015; 99: 1386-1395.
  • Kwek JL, Tey V, Yang LY, Kanagalingam D, Kee T. Renal and Obstretric Outcomes in Pregnancy after Kidney Transplantation – A Twelve Year Experience in a Singapore Transplant Center. Journal of Obs and Gyn Research 2015; 41: 1337-1344.
  • Budde K, Bunnapradist S, Grinyo JM, et al on behalf of the Envarsus study group. Novel Once-Daily Extended-Release Tacrolimus (LCPT) Versus Twice-Daily Tacrolimus in De Novo Kidney Transplants: One-Year Results of Phase III, Double-Blind, Randomized Trial. Am J Transplant 2014; 14: 2796-2808.
  • Wong NY, Chin CT, Tee PS, Khin LW, Koh AS, Kee T, Tan WC. Risk factors for cardiovascular events among Asian patients without pre-existing cardiovascular disease on the renal transplant wait-list. Asia Pacific Heart Journal 2015; 23: 1-7. 
  • Huang K, Cheah S,  Kee T, Ng  C.  Physical function and body composition in Asian kidney transplant recipients over time with physiotherapy intervention. Proceedings of Singapore Healthcare 2015; 24: 208-212. 
  • Kee T. Editorial: Kidney Transplantation during Singapore’s Golden Jubilee: Reflections of the Past and Meeting the Challenges in the next 50 years. Proceedings of Singapore Healthcare 2015; 24: 206-207.
  • Woo KT, Thangaraju S, Kee T. Renal Transplantation: Then and Now. Proceedings of Singapore Healthcare 2015; 24: 203-205.
  • Wong NY, Tee PS, Kee T. Tan J. Current Practices in Cardiovascular Evaluation Prior to Renal Transplantation. Proceedings of Singapore Healthcare 2015; 24: 213-218.
  • Woo KT, Chan CM, Choong HL, Wong KS, Tan HK, Kee T, Foo M. A common gene signature to tolerance in renal allograft. Kidney Int 2015; 88: 1447-1448.

Research Trials